Cubist Systematic Strategies, LLC Harrow Health, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $469,508 - $728,009	33,924 Added 60.5%	90,000 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $410,696 - $590,475	39,951 Added 247.76%	56,076 $827,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $35,208 - $133,331	5,359 Added 49.78%	16,125 $195,000
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $61,904 - $83,328	10,766 New	10,766 $78,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $162,664 - $246,672	-23,271 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $155,450 - $257,609	23,271 New	23,271 $216,000
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $42,147 - $87,304	-10,035 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $47,666 - $71,248	10,035 New	10,035 $50,000

176

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.